1. Acemoglu D, Linn J (2004) Market size in innovation: theory and evidence from the pharmaceutical industry. Q J Econ 119(3):1049–1090
2. Aldous G, Falconer D, Aldous W (1965) Terrel on the law of patents, 11th edn. Sweet & Maxwell, London
3. Angulo FJ, Collignon P, Powers JH, Chiller TM, Aidara-Kane A, Aarestrup FM (2009) World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clin Infect Dis 49(1):132–141
4. Årdal C, Findlay D, Savic M, Carmeli Y, Gyssens I, Laxminarayan R, Outterson K, Rex JH (2018) DRIVE-AB report—revitalizing the antibiotic pipeline: stimulating innovation while driving sustainable use and global access.
https://carb-x.org/wp-content/uploads/2018/01/DRIVE-AB_Final_Report-Jan2018.pdf
. Accessed 25 Nov 2018
5. Azoulay P, Graff Zivin JS, Li D, Sampat BN (2018) Public R&D investments and private-sector patenting evidence from NIH funding rules. Rev Econ Stud 0:1–36